Our group has clarified the effect of insulin resistance on AD pathology using AD model mice harboring the P1195L mutation in the insulin receptor, which diminishes the receptor tyrosine kinase activity to induce insulin resistance.14, 15. This evidence concerns the gene NTRK1 and Insulin resistance.